Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain

Neuropsychopharmacology

Volumn 23, Issue 2, 2000, Pages 205-215

  Müller, Marianne B ^a   Toschi, Nicola ^a   Kresse, Adelheid E ^a,b   Post, Anke ^a   Keck, Martin E ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

BDNF; CCK; Depression; Dopamine; Neuroprotection; NPY; rTMS

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLECYSTOKININ; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; CHOLECYSTOKININ; DENTATE GYRUS; ELECTRIC STIMULATION; HIPPOCAMPUS; MALE; NEUROPEPTIDE Y; OLFACTORY PATHWAYS; PARIETAL LOBE; RATS; RATS, WISTAR; RNA, MESSENGER; TIME; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0038214658     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00099-3     Document Type: Article

References (67)

1. Altar C.A. Neurotrophins and depression. Trends Pharmacol Sci. 20:1999;59-61.
2. Ben-Shachar D., Belmaker R.H., Grisaru N., Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm. 104:1997;191-197.
3. Bickford R.G., Guidi M., Fortesque P., Swenson M. Magnetic stimulation of human peripheral nerve and brain. Response enhancement by combined magnetoelectrical technique Neurosurgery. 20:1987;110-116.
4. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 15:1994;220-226.
5. Brodin K., Ögren S.-O., Brodin E. Clomipramine and clonazepam increase cholecystokinin levels in rat ventral tegmental area and limbic regions. Eur J Pharmacol. 263:1994;175-180.
6. Brodin K., Rosén A., Iwarsson K., Ögren S.-O., Brodin E. Increased levels of substance P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with a serotonin uptake inhibitor. Acta Physiol Scand. 136:1989;613-614.
7. Castrén E., Berninger B., Leingartner A., Lindholm D. Regulation of brain-derived neurotrophic factor mRNA levels in hippocampus by neuronal activity. Progr Brain Res. 117:1998;57-64.
8. Cerri G., De Leo R., Moglie F., Schiavoni A. An accurate 3-D model for magnetic stimulation of the brain cortex. J Med Eng Tech. 19:1995;7-16.
9. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS. Evidence for anterograde axonal transport J Neurosci. 17:1997;2295-2313.
10. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev. 27:1998;1-39.
11. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides. 15:1994;731-755.
12. Deschenes R.J., Lorenz L.J., Haun R.S., Roos B.A., Collier K.J., Dixon J.E. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci USA. 81:1984;726-730.
13. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;597-606.
14. Fibiger H.C. Neurobiology of depression. focus on dopamine Gessa G., Fratta W., Pani L., Serra G. Depression and Mania. From Neurobiology to Treatment:1995;1-17 Raven Press, New York.
15. Finkbeiner S., Tavazoie S.F., Maloratsky A., Jacobs K.M., Harris K.M., Greenberg M.E. Creb. A major mediator of neuronal neurotrophin responses Neuron. 19:1997;1031-1047.
16. Fishback A.S., Shields C.B., Linden R.D., Zhang Y.P., Burke D. The effects of propofol on rat transcranial magnetic motor evoked potentials. Neurosurgery. 37:1995;969-974.
17. Fleischmann A., Prolov K., Abarbanel J., Belmaker R.H. The effect of transcranial magnetic stimulation of rat brain on behavior. Models of depression Brain Res. 699:1995;130-132.
18. Freund T.F., Buzsáki G. Interneurons of the hippocampus. Hippocampus. 6:1996;347-470.
19. George M.S., Wassermann E.M., Kimbrell T.A., Little J.T., Williams W.E., Danielson A.L., Greenberg B.D., Hallett M., Post R.M. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression. A placebo-controlled crossover trial Am J Psychiatry. 154:1997;1752-1756.
20. George M.S., Lisanby S.H., Sackheim H.A. Transcranial magnetic stimulation. Arch Gen Psychiatry. 56:1999;300-311.
21. Gjerris A., Widerlov E., Werdelin L., Ekman R. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatry Neurosci. 17:1992;23-27.
22. Greenwood R.S., Godar S.E., Reaves T.A., Hayward J.N. Cholecystokinin in hippocampal pathways. J Comp Neurol. 203:1981;335-350.
23. Grisaru N., Chudakov B., Yaroslavsky Y., Belmaker R.H. Catatonia treated with transcranial magnetic stimulation. Am J Psychiatry. 155:1998;1630. a.
24. Grisaru N., Chudakov B., Yaroslavsky Y., Belmaker R.H. Transcranial magnetic stimulation in mania. A controlled study Am J Psychiatry. 155:1998;1608-1610. b.
25. Heilig M., Wahlestedt C., Ekman R., Widerlov E. Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur J Pharmacol. 147:1988;465-467.
26. Heilig M., Widerlov E. Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol. 9:1995;115-136.
27. Hökfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of DA and CCK in meso-limbic neurones. Nature. 285:1980;476-478.
28. Holsboer F. Neuroendocrinology of mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress:1995;957-968 Raven Press, New York.
29. Jennum P., Klitgaard H. Repetitive transcranial magnetic stimulations of the rat. Effect of acute and chronic stimulations on pentylenetetrazole-induced clonic seizures. Epilepsy Res. 23:1996;115-122.
30. Ji R.-R., Schlaepfer T., Aizenman C.D., Epstein C.M., Qiu D., Huang J.C., Rupp F. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc Natl Acad Sci USA. 95:1998;15635-15640.
31. Kalkman C.J., Drummond J.C., Ribberink A.A., Patel P.M., Sano T., Bickford R.G. Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans. Anesthesiology. 76:1992;502-509.
32. Keck M.E., Sillaber I., Ebner K., Welt T., Kaehler S.T., Singewald N., Philippu A., Elbel G.K., Curt A., Wotjak C.T., Landgraf R., Engelmann M. Neurochemical effects of acute rapid-rate transcranial magnetic stimulation. An intracerebral microdialysis study Soc Neurosci Abstr. 24:1998;746.
33. Kokaia Z., Zhao Q., Kokaia M., Elmer E., Metsis M., Smith M.-L., Siesjö B.K., Lindvall O. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp Neurol. 136:1995;73-88.
34. Kononen J., Hökfelt T., Pelto-Hiokko M. Effects of ageing on the expressions of neurotrophins and their receptors in the rat pituitary gland. NeuroReport. 6:1995;2429-2434.
35. Kresse A., Jacobowitz D.M., Skofitsch G. Detailed mapping of CGRP mRNA expression in the rat central nervous system. Comparison with previous immunocytochemical findings Brain Res Bull. 36:1995;261-274.
36. Larhammar D., Ericsson A., Persson H. Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci USA. 84:1987;2068-2072.
37. Lindefors N., Brodin K., Stiller C.O., Persson H., Brodin E. Repeated electroconvulsive shock increases tachykinin and cholecystokinin mRNA expression in ventral periaqueductal gray. Neuroscience. 45:1991;73-80.
38. Lindholm D., Dechant G., Heisenberg C.P., Thoenen H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur J Neurosci. 5:1993;1455-1464.
39. Maisonpierre P.C., Le Beau M.M., Espinoza R., Ip N.Y., Belluscio L., de la Monte S.M., Squinto S., Furth M.E., Yancopoulos G.D. Human and rat brain-derived neurotrophic factor and neurotrophin-3. gene structures, distributions, and chromosomal localizations Genomics. 10:1991;558-568.
40. Mikkelsen J.D., Woldbye D., Kragh J., Larsen P.J., Bolwig T.G. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and dentate gyrus. Mol Brain Res. 23:1994;317-322.
41. + conductance in hippocampal interneurons. J Neurosci. 17:1997;4994-5003.
42. Moran T.H., Schwartz G.J. Neurobiology of cholecystokinin. Crit Rev Neurobiol. 9:1994;1-28.
43. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 15:1995;7539-7547.
44. Nibuya M., Nestler E., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
45. Orzi F., Zoli M., Passarelli F., Ferraguti F., Fieschi C., Agnati L.F. Repeated electroconvulsive shock increases glial fibrillary acidic protein, ornithine decarboxylase, somatostatin and cholecystokinin immunoreactivities in the hippocampal formation of the rat. Brain Res. 533:1990;223-231.
46. Pascual-Leone A., Catala M.D. Lasting beneficial effect of rapid rate transcranial magnetic stimulation on slowness in Parkinson's disease. Neurology. 45:1995;550.
47. Pascual-Leone A., Rubio B., Pallardo F., Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348:1996;233-237.
48. Pascual-Leone A., Valls-Solé J., Brasil-Neto J.P., Cammarota A., Grafman J., Hallett M. Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology. 44:1994;892-898.
49. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 7:1991;695-702.
50. Post A., Müller M.B., Engelmann M., Keck M.E. Repetitive transcranial magnetic stimulation in rats - evidence for a neuroprotective effect in vitro and in vivo. Eur J Neurosci. 11:1999;3247-3254.
51. Rossini P.M., Rossi S. Clinical applications of motor evoked potentials. Electroencephalogr Clin Neurophysiol. 106:1998;180-194.
52. Schalling M., Friberg K., Seroogy K., Riederer P., Bird E., Schiffmann S.N., Mailleux P., Vanderhaeghen J.J., Kuga S., Goldstein M., Kitahama K., Luppi P.H., Jouvet M., Hökfelt T. Analysis of the expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. Proc Natl Acad Sci USA. 87:1990;8427-8431.
53. Schuman E.M. Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol. 9:1999;105-109.
54. Shimohama S., Tamura Y., Akaike A., Tsukahara T., Ohara O., Watanabe S., Kimura J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci Lett. 164:1993;55-58.
55. Siebner H.R., Mentschel C., Auer C., Conrad B. Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease. NeuroReport. 10:1999;589-594.
56. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 56:1997;131-137.
57. Smith M.A., Zhnag L.-X., Lyons W.E., Mamounas L.A. Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. NeuroReport. 8:1997;1829-1834.
58. Somogyi P., Hodgson A.J., Smith A.D., Nunzi M.G., Gorio A., Wu J.-Y. Different populations of GABAergic neurons in the visual cortex and the hippocampus of cat contain somatostatin or cholecystokinin-immunoreactive material. J Neurosci. 14:1984;2590-2603.
59. Takahashi M., Terwilliger R., Lane C., Mezes P.S., Conti M., Duman R.S. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J Neurosci. 19:1999;610-618.
60. van der Kooy D., Hunt S., Steinbusch H.W.M., Verhofstad A.A.J. Separate populations of cholecystokinin and 5HT-containing cells in the dorsal raphe and their contribution to its ascending projections. Neurosci Lett. 26:1981;25-30.
61. van Groen T., Wyss J.M. Extrinsic projections from area CA1 of the rat hippocampus. olfactory, cortical, subcortical, and bilateral hippocampal formation projections J Comp Neurol. 302:1990;515-528.
62. Wahlestedt C., Blendy J.A., Kellar K.J., Heilig M., Widerlov E., Ekman R. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res. 507:1990;65-68.
63. Widdowson P.S., Ordway G.A., Halaris A.E. Reduced neuropeptide Y concentrations in suicide brain. J Neurochem. 59:1992;73-80.
64. You Z.-B., Tzschentke T.M., Brodin E., Wise R.A. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate and dopamine release in the nucleus accumbens. An in vivo microdialysis study in freely moving rats J Neurosci. 18:1998;6492-6500.
65. Zetterström T.S., Pei Q., Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res. 57:1998;106-110.
66. Zhang L.X., Smith M.A., Kim S.Y., Rosen J.B., Weiss S.R., Post R.M. Changes in cholecystokinin mRNA expression after amygdala kindled seizures. An in situ hybridization study Mol Brain Res. 35:1996;278-284.
67. Zyss T., Gorka Z., Kowalska M., Vetulani J. Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat. Biol Psychiatry. 42:1997;920-924.